Oxford Immunotec Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Oxford Immunotec Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6591
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec’s T-SPOT solution offers diagnosing disease by measuring immune response to an infection. The company offers laboratories services such as oxford diagnostics. It operates in the US, the UK, Japan, South Korea and China. Oxford Immunotec is headquartered in Abingdon, the UK.

Oxford Immunotec Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Immunotec Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Immunotec Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oxford Immunotec Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Immunotec Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Oxford Immunotec Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oxford Immunotec Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Oxford Immunotec Raises US$28 Million In Venture Financing 10
Partnerships 12
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For Urea Technology 12
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For T-Spot Technology 13
Asset Transactions 14
Quest Diagnostics to Acquire US Laboratory Services Business from Oxford Immunotec for USD170 Million 14
Oxford Immunotec Ltd – Key Competitors 15
Oxford Immunotec Ltd – Key Employees 16
Oxford Immunotec Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Jul 31, 2018: Oxford Immunotec reports second quarter 2018 financial results 18
May 01, 2018: Oxford Immunotec Reports First Quarter 2018 Financial Results 19
Feb 27, 2018: Oxford Immunotec Reports Fourth Quarter and Full Year 2017 Financial Results 20
May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results 22
Corporate Communications 24
Mar 01, 2018: Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors 24
Product News 25
May 22, 2018: Oxford Immunotec Announces Launch of the Accutix Brand 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Oxford Immunotec Ltd, Medical Equipment, Key Facts, 2016 2
Oxford Immunotec Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Oxford Immunotec Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Immunotec Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oxford Immunotec Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Immunotec Ltd, Deals By Market, 2012 to YTD 2018 8
Oxford Immunotec Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oxford Immunotec Raises US$28 Million In Venture Financing 10
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For Urea Technology 12
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For T-Spot Technology 13
Quest Diagnostics to Acquire US Laboratory Services Business from Oxford Immunotec for USD170 Million 14
Oxford Immunotec Ltd, Key Competitors 15
Oxford Immunotec Ltd, Key Employees 16
Oxford Immunotec Ltd, Subsidiaries 17

List of Figures
Oxford Immunotec Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Oxford Immunotec Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Oxford Immunotec Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Oxford Immunotec Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Oxford Immunotec Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Immunotec Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Oxford Immunotec Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Immunotec Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Oxford Immunotec Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Huawei Investment & Holding Co., Ltd.:企業のM&A・事業提携・投資動向
    Huawei Investment & Holding Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huawei Investment & Holding Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • TAE Aerospace:企業の戦略・SWOT・財務情報
    TAE Aerospace - Strategy, SWOT and Corporate Finance Report Summary TAE Aerospace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務情報
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CGU Insurance Limited:企業の戦略・SWOT・財務情報
    CGU Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary CGU Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Becle S.A.B. de C.V. (CUERVO) -Financial and Strategic SWOT Analysis Review
    Becle S.A.B. de C.V. (CUERVO) -Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Rafako SA (RFK):電力:M&Aディール及び事業提携情報
    Summary Rafako SA (Rafako), a subsidiary of PBG SA is a power generation equipment manufacturer that designs and distributes boilers and environment protection units. The company provides a range of boilers such as PC boilers, circulating fluidized bed (CFB) boilers, heat recovery steam generator (H …
  • Broadwind Energy Inc (BWEN):電力:M&Aディール及び事業提携情報
    Summary Broadwind Energy Inc (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. The …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HoMedics LLC:企業の戦略的SWOT分析
    HoMedics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Lay Hong Berhad (LAYHONG):企業の財務・戦略的SWOT分析
    Lay Hong Berhad (LAYHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MRC Global Inc (MRC):企業の財務・戦略的SWOT分析
    MRC Global Inc (MRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Entreprise Tunisienne d’Activites Petrolieres:企業の戦略的SWOT分析
    Entreprise Tunisienne d'Activites Petrolieres - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • The Tokyo Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    The Tokyo Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Polyphor AG (POLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Polyphor AG (Polyphor) is a clinical stage biopharmaceutical company that discovers and develops antibiotics and other specialty pharma products for severe or life-threatening diseases. The company offers hematopoietic stem cells for multiple myeloma patients, Pseudomonas infections and prot …
  • NTN Corporation (6472):企業の財務・戦略的SWOT分析
    NTN Corporation (6472) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccitech Ltd (Vaccitech) is a clinical stage company that focuses on the development of universal flu vaccines. The company is developing clinical programs for the treatment of influenza, prostate cancer, HBV, Middle East respiratory syndrome (MERS), shingles, human papillomavirus (HPV), an …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆